1. Home
  2. WLY vs TWST Comparison

WLY vs TWST Comparison

Compare WLY & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • TWST
  • Stock Information
  • Founded
  • WLY 1807
  • TWST 2013
  • Country
  • WLY United States
  • TWST United States
  • Employees
  • WLY N/A
  • TWST N/A
  • Industry
  • WLY Books
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WLY Consumer Discretionary
  • TWST Health Care
  • Exchange
  • WLY Nasdaq
  • TWST Nasdaq
  • Market Cap
  • WLY 2.2B
  • TWST 2.6B
  • IPO Year
  • WLY N/A
  • TWST 2018
  • Fundamental
  • Price
  • WLY $45.50
  • TWST $38.21
  • Analyst Decision
  • WLY
  • TWST Buy
  • Analyst Count
  • WLY 0
  • TWST 10
  • Target Price
  • WLY N/A
  • TWST $52.50
  • AVG Volume (30 Days)
  • WLY 572.7K
  • TWST 1.0M
  • Earning Date
  • WLY 03-06-2025
  • TWST 05-01-2025
  • Dividend Yield
  • WLY 3.12%
  • TWST N/A
  • EPS Growth
  • WLY N/A
  • TWST N/A
  • EPS
  • WLY 0.75
  • TWST N/A
  • Revenue
  • WLY $1,703,491,000.00
  • TWST $330,189,000.00
  • Revenue This Year
  • WLY N/A
  • TWST $22.62
  • Revenue Next Year
  • WLY $1.13
  • TWST $17.76
  • P/E Ratio
  • WLY $60.05
  • TWST N/A
  • Revenue Growth
  • WLY N/A
  • TWST 25.85
  • 52 Week Low
  • WLY $34.85
  • TWST $27.41
  • 52 Week High
  • WLY $53.96
  • TWST $60.90
  • Technical
  • Relative Strength Index (RSI)
  • WLY 61.59
  • TWST 39.46
  • Support Level
  • WLY $43.96
  • TWST $37.12
  • Resistance Level
  • WLY $45.00
  • TWST $40.80
  • Average True Range (ATR)
  • WLY 0.88
  • TWST 2.48
  • MACD
  • WLY -0.01
  • TWST -0.12
  • Stochastic Oscillator
  • WLY 96.76
  • TWST 13.41

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: